The Covid-19 Plasma Boom Is Over. What Did We Learn From It?

Health
By BY KATIE THOMAS AND NOAH WEILAND from NYT Health https://ift.tt/3dnhMdr
via IFTTT your-feed-science, Antibodies, Blood Donation, Coronavirus (2019-nCoV), Clinical Trials, Government Contracts and Procurement, Blood, United States Politics and Government, your-feed-healthcare The U.S. government invested $800 million in plasma when the country was desperate for Covid-19 treatments. A year later, the program has fizzled.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda